Biofidelity launches Aspyre® Lung Reagents, now enabling integrated tissue and liquid biopsy analysis
recent articles
Lumea: The FDA's recent move to treat Laboratory Developed Tests (LDTs) as medical devices has sent ripples through the industry. With the absence of a passed legislation in 2022, the FDA has taken a pivotal step, emphasizing its...
PathAI: The lab will support clinical trials across oncology, liver, and GI indications, with expansion to additional indications in the future. Boston, MA – September 19, 2023 – PathAI, a global leader in AI-powered pathology,...
Lunit 6 posters unveil new tumor microenvironment insights and the predictive power of Lunit SCOPE across diverse cancer types at SITC 2023 SEOUL, South Korea, Sept. 27, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of...
SEOUL, South Korea, Oct. 4, 2023 /PRNewswire/ -- Deep Bio, a leader in artificial intelligence (AI)-powered cancer diagnostics, announced today that it has been named to the Korea AI Startup 100 list. This prestigious list, representing a...
Indica Labs: Learn how to implement Lung PD-L1 AI to assist PD-L1 scoring in non-small cell lung cancer. Lung PD-L1 AI: Development and Validation of an Automated PD-L1 Tumor Proportion Scoring Algorithm in Non-Small Cell Lung...
mTuitive: Cancer Surgeons, Pathologists, Researchers, and Patients will all Benefit from First-of-its-Kind Health Informatics Solution CENTERVILLE, Mass., October 2, 2023 - mTuitive, a leading provider of data enablement solutions for...
